Home › Funds › WELLINGTON MANAGEMENT GROUP LLP › AZN

WELLINGTON MANAGEMENT GROUP LLP position in AZN

ASTRAZENECA PLC · Health Care

WELLINGTON MANAGEMENT GROUP LLP reported holding 30,837,503 shares of AZN (ASTRAZENECA PLC) in its Q3 2026 13F filing — a position valued at US$5.01B, representing 0.99% of its reported portfolio and ranking #13 among its reported holdings. WELLINGTON MANAGEMENT GROUP LLP has disclosed AZN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)30.84M sh
Reported value held$5.01B
Portfolio Weight0.99%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How WELLINGTON MANAGEMENT GROUP LLP's AZN position evolved

WELLINGTON MANAGEMENT GROUP LLP first disclosed a stake in AZN in Q3 2023 at 49,492,814 shares (US$3.35B). The position peaked in Q2 2026 at 28,537,243 shares, worth US$5.36B. Across 13 filings, WELLINGTON MANAGEMENT GROUP LLP increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 30,837,503 shares valued at US$5.01B — an increase of 2,300,260 shares quarter over quarter.. Notable position changes include a 29% trim in Q4 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 49.49M $3.35B New
Q4 2023 49.44M $3.33B Hold
Q1 2024 49.12M $3.33B Reduce
Q2 2024 40.57M $3.16B Reduce
Q3 2024 37.25M $2.90B Reduce
Q4 2024 37.04M $2.43B Reduce
Q1 2025 35.63M $2.62B Reduce
Q2 2025 34.34M $2.40B Reduce
Q3 2025 32.30M $2.48B Reduce
Q4 2025 22.83M $2.10B Reduce
Q1 2026 23.75M $4.63B Add
Q2 2026 28.54M $5.36B Add
Q3 2026 30.84M $5.01B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 61 other funds we track also report a position in AZN — the largest reported positions include INVESTOR AB (US$9.78B), Norges Bank Investment Management (US$6.33B), Capital World Investors (US$5.63B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has WELLINGTON MANAGEMENT GROUP LLP held AZN?

WELLINGTON MANAGEMENT GROUP LLP has disclosed AZN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WELLINGTON MANAGEMENT GROUP LLP's current position in AZN?

As of Q3 2026, WELLINGTON MANAGEMENT GROUP LLP holds 30.84M shares of AZN (ASTRAZENECA PLC), valued at $5.01B, representing 0.99% of its reported portfolio and ranking #13.

Has WELLINGTON MANAGEMENT GROUP LLP been buying or selling AZN?

In the latest 13F filing (Q3 2026), WELLINGTON MANAGEMENT GROUP LLP increased its position in AZN. The position peaked in Q2 2026 at 28.54M shares.

Which other funds hold AZN?

Other major institutional holders of AZN include INVESTOR AB, Norges Bank Investment Management, Capital World Investors, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.